Despite Enbrel Risks, FDA Panel Backs it for Children with Psoriasis
FDA Recommends Enbrel for Psoriasis in Children. A Food & Drug Administration (FDA) advisory panel has recommended that the agency approve Enbrel to treat moderate-to-severe psoriasis in children, despite concerns that the drug has been linked to cancer and serious infections, including tuberculosis. Enbrel is already … [Read more...] about Despite Enbrel Risks, FDA Panel Backs it for Children with Psoriasis
Enbrel Infection Risk
Enbrel Infection Risk. Enbrel has been linked to sometimes deadly infections when administered to children, casting doubts that the Food & Drug Administration (FDA) will approve the Amgen and Wyeth drug to treat severe psoriasis in children. Enbrel is already approved to treat psoriasis and rheumatoid arthritis in adults and … [Read more...] about Enbrel Infection Risk
